In this study, the hypothesis that mammalian ventricular myocytes possess A2-adenosine receptors was tested. Electrophysiological, contractile, and cAMP responses to the selective A2-adenosine receptor agonists 2-[2-(4-methylphenyl)ethoxyladenosine (WRC-0090) and 2-(2-cyclohexylethoxy)adenosine (WRC-0013) and the nonselective adenosine receptor agonist 5'-(N-ethylcarboxamido)adenosine (NECA) were measured using ventricular myocytes isolated from guinea pig, rabbit, and rat hearts. Pertussis toxin pretreatment and/or the selective A,-adenosine receptor antagonists 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) and (+)N6-endonorbornan-2-yl-9-methyladenine (N-0861) were used to prevent activation of A,-adenosine receptors on these cells. Action 
and from embryonic chicken hearts21 is both inhibited by A1-adenosine receptors and stimulated by A2-adenosine receptors. A2-Adenosine receptor-mediated stimulation of adenylyl cyclase activity by NECA was masked by concomitant activation of A,-adenosine receptors that inhibited the enzyme.19,20 NECA was found to stimulate adenylyl cyclase activity in embryonic chick ventricular myocytes pretreated with pertussis toxin or incubated with 1,3 -dipropyl- 8 -cyclopentylxanthine (DPCPX) to attenuate A,-adenosine receptor-mediated actions. 21 Interestingly, NECA does not appear to increase contractility of guinea pig isolated ventricular myocytes, 20, 22 and functional responses associated with activation of adenylyl cyclase, such as increased calcium inward current, positive inotropy, or lengthening of action potential duration (APD), have not been convincingly demonstrated in a mammalian cardiac cell incubated with adenosine or with adenosine analogues.
Because a large number of cells are needed to perform cAMP or adenylyl cyclase assays, contamination of myocyte preparations with nonmyocytes could explain results indicating the presence of A2-adenosine receptors in cardiac preparations. Thus, functional responses recorded from single cells under visual observation are needed to conclusively demonstrate the existence of A2-adenosine receptors on mammalian ventricular myocytes.
Highly selective agonists or antagonists with which to assess the presence and function of the A2-adenosine receptor in cardiac tissues are not commercially available. Recently, however, the synthesis and selectivities of two novel series of adenosine derivatives were described.2324 We selected two of these derivatives for experimental use: 2-(2-cyclohexylethoxy)adenosine, a 2-alkoxyadenosine (referred to as No. 3m by Ueeda et al,23 but renamed WRC-0013); and 2-[2-(4-methylphenyl)ethoxy]adenosine, a 2-aralkoxyadenosine (referred to as No. 19 by Ueeda et al, 24 but renamed WRC-0090). They were, respectively, 8,700-fold and 44,000-fold more potent in increasing coronary flow (an A2-mediated effect) of the guinea pig isolated perfused heart than in causing prolongation of the stimulus-QRS interval (an A,-mediated effect).23 '24 The goal of the present study was to investigate the actions of these two selective A2-adenosine receptor agonists on ventricular myocytes isolated from guinea pig, rabbit, and rat hearts. Electrophysiological and contractile responses and cAMP content were measured. Because even selective A2-adenosine receptor agonists might not be sufficiently A2 selective in myocytes, for the purpose of this study, it was necessary to attenuate Al-adenosine receptor-mediated responses, which may obscure responses to activation of A2-adenosine receptors. Two experimental approaches were used. In some experiments, A,-adenosine receptormediated effects were attenuated by using the A, subtype-selective antagonists (±+)N6-endonorbornan-2-yl- 9 -methyladenine (N-0861)25 and DPCPX. 26 In other experiments, animals or isolated myocytes were pretreated with pertussis toxin to uncouple the A,-adenosine receptor from inhibitory G proteins. The validity of these experimental approaches was demonstrated by parallel studies using DDT1MF-2 cells. In these cells, the presence of both Al-and A2-adenosine receptor subtypes has been demonstrated by use of radioligand binding with adenosine receptor subtype-selective probes and adenylyl cyclase assays. 7 The results of our experiments do not provide evidence for functional A2-adenosine receptors on mammalian ventricular myocytes but demonstrate their presence on DDT1MF-2 cells.
Materials and Methods

Chemicals
Two analogues of adenosine with high selectivity for the A2-adenosine receptor, WRC-0090 and WRC-0013,23,24 were synthesized and provided by Dr. R.A. Olsson, University of South Florida, Tampa, with the permission of Whitby Research, Richmond, Va. Stock solutions (10 mM) were prepared in dimethyl sulfoxide and diluted at least 1,000-fold in saline for use in experiments. The selective A,-adenosine receptor antagonist N-0861 was a gift from Whitby Research, Richmond, Va. The selective A1-adenosine receptor antagonist DPCPX and the nonselective adenosine receptor antagonist xanthine amine congener were purchased from Research Biochemicals, Natick, Mass. Pertussis toxin was a gift from Dr. Eric Hewlett, University of Virginia, Charlottesville. Forskolin, adenosine deaminase, and bovine serum albumin were from Sigma Chemical Co., St. Louis, Mo. Collagenase was purchased from Worthington Biochemical, Freehold, N.J.; dispase was from Boehringer Mannheim Corp., Indianapolis, Ind.; and trypsin was from Serva Fine Biochemicals, Heidelberg, FRG. Rolipram, a phosphodiesterase inhibitor selective for the low Km cAMP-specific form(s) of phosphodiesterase,27 was a gift from Berlex Labs, Cedar Knolls, N.J., and was prepared and stored as a 50-mM stock solution in dimethyl sulfoxide.
Preparation of Isolated Ventricular Myocytes
Adult guinea pigs and rats of either sex were anesthetized with methoxyflurane. Rabbits were anesthetized with ketamine and acepromazine. The chest was opened, and the heart was quickly excised and placed into an ice-cold modified Krebs-Henseleit (K-H) solution containing (mM) NaCl 127, KCI 4.6, CaCl2 2, MgSO4 1.1, sodium pyruvate 2, glucose 10, creatine 10, taurine 20, ribose 5, adenine 0.01, allopurinol 0.1, and sodium HEPES 5, pH 7.4. The aorta was cannulated, and retrograde perfusion of the heart was begun with warmed (35°C), oxygenated (100% 02) solutions at a rate of 8 ml/min for guinea pig and rat hearts and 16 ml/min for rabbit hearts. The following solutions were perfused in sequence: 1) modified K-H solution for 10 minutes, 2) Ca2+-free K-H solution for 10 minutes, 3) Ca2+-free solution containing (mg/ml) collagenase type II 0.4, dispase 0.04, trypsin 0.04, and albumin 2 for 20 minutes. The heart was then removed from the cannula, and the ventricles were minced with scissors. The minced tissue was further incubated at 35°C in a shaker bath to dissociate cells. Dissociated cells were stored at room temperature in modified K-H solution containing 0.1 mM Ca21 until use. Only quiescent rod-shaped myocytes with clear striations were used for electrophysiology or contraction studies.
In some experiments, collagenase (0.6 mg/ml) alone was used to digest guinea pig isolated hearts to avoid possible proteolysis of cell surface adenosine receptors by trypsin. The freshly dissociated ventricular myocytes were incubated for 2 hours at 22°C in a modified KB medium28 to prevent development of calcium overload and facilitate cellular recovery of calcium tolerance. This medium contained (mM) KCI 80, K2HPO4 30, MgSO4 5, Na2ATP 5, pyruvic acid 5, ,B-hydroxybutyric acid 5, creatine 5, taurine 20, and glucose 20, with pH adjusted to 7.0. During the second hour of incubation, free calcium concentration of the medium was increased in two steps to 100 ,uM. Cells were allowed to settle, and the supernate (containing damaged cells) was aspirated. Cells were then incubated in a Petri dish in an atmosphere of 5% C02-95% air for 3 hours at 37°C in medium 199 (calcium concentration, 1.8 mM) with 2% bovine calf serum, 1 mM ascorbic acid, and 1 unit/ml adenosine deaminase. When appropriate, pertussis toxin (10 ,ug/ml) was added to the incubation medium to uncouple A1-adenosine receptors from inhibitory G proteins. Cells were transferred to a glass tube and allowed to settle, and the supernate was aspirated and replaced with modified K-H solution at room temperature containing 2 mM calcium and 1 unit/ml adenosine deaminase; this step was repeated twice in 1 hour. In two experiments with guinea pig atrial myocytes, 50 ,uM theophylline and 1 unit/ml adenosine deaminase were added to all media (isolation, recovery, and pretreatment) to reduce the potential for desensitization of A2-adenosine receptors by adenosine. Cells exposed to theophylline were then washed three times with fresh K-H solution before use.
Two modifications of the above procedure were made to increase myocyte stability for measuring cell shortening in response to drugs. After incubation in medium 199, cells were resuspended in a physiological saline solution (see "Measurement of Cell Shortening") containing 0.1 mM calcium, rather than 2 mM calcium, before use in experiments. Also, the addition of 1.5 mM Na2EDTA to medium 199 to reduce the free calcium concentration during the 3-hour control/pertussis toxin treatment was found to enhance subsequent inotropic responses of myocytes to isoproterenol.
Myocyte electrophysiological, contractile, or cAMP responses to A2-adenosine receptor agonists were qualitatively similar comparing myocytes isolated by the "4collagenase alone" and the "collagenase/dispase/trypsin" protocols.
Electrophysiology
Isolated ventricular myocytes were placed into an experimental chamber (volume, 0.5 ml) fixed to the stage of a Zeiss inverted microscope and superfused at a rate of 2 ml/min with modified K-H solution (2 mM Ca21) warmed to 35°C. For experiments with rat ventricular myocytes, the potassium concentration of the superfusate was raised to 15 mM to prevent depolarization of cells upon impalement with a microelectrode. 29 Single microelectrodes (resistance, 30-50 MQ) filled with 3 M KCI were used for both stimulation and recording of transmembrane resting and action potentials. The ranges of resting membrane potentials of ventricular myocytes isolated from guinea pigs, rabbits, and rats were -83 to -87, -80 to -87, and -40 to -54 mV, respectively. Action potentials were elicited by brief (5-msec) rectangular current pulses applied at a rate of 0.5 Hz between the intracellular electrode and a grounded bath electrode. Membrane voltage was amplified with an Axoclamp-2A (Axon Instruments, Burlingame, Calif.) and recorded by a strip-chart recorder (model 2200S, Gould, Cleveland, Ohio). Recordings of membrane action potentials were obtained before and after the addition of drugs. Cells were exposed for 4 minutes each to various concentrations of drugs. APD was measured at 50% repolarization (APD50).
Measurement of Cell Shortening
Freshly isolated ventricular myocytes from guinea pig, rat, or rabbit hearts were suspended in a physiological saline solution containing (mM) NaCl 118, KCl 4.78, CaCl2 1.2, MgCl2 1.1, glucose 10, sodium HEPES 10, pH 7.4. An aliquot of cell suspension was placed in a recording chamber (volume, 1-1.5 ml) mounted on the stage of a Nikon Diaphot inverted microscope. The microscope image was captured using an Ikegami ITC-510 videcon CCTV camera and displayed on a 17-in. CCTV picture monitor (Ikegami Electronics, Haywood, N.J.). The unloaded contraction of a single myocyte was quantitated using a video edge detector (Crescent Electronics, Logan, Utah) to measure the extent of movement of a cell edge along a selected raster line segment of the TV image. The voltage output of the edge detector was displayed on an oscilloscope (Nicolet Instrument Corp., Madison, Wis.) and recorded by a Gould strip-chart recorder. New position data was obtained every 16.7 msec. The amplitude of cell wall motion was measured from the strip-chart recording and calibrated to obtain motion in microns. The amplitude of cell wall motion is an index of contractility. 30 Twitch shortening of myocytes was elicited by rectangular current pulses (0.1-0.2 mA in amplitude and 2.5-5 msec in duration at a rate of 40 pulses per minute) applied between an extracellular micropipette and a remote silver-wire electrode. The extracellular glass micropipette was filled with physiological saline solution (see above) and positioned with its tip 10-25 ,um from the myocyte to be stimulated. Myocytes were superfused with 35°C physiological saline solution at 2 ml/min. Exposures of myocytes to drugs were kept as short as possible (approximately 2-3 minutes) to avoid desensitization but still allow attainment of an acute maximal response.
DDT1MF-2 Cells
DDTIMF-2 (a cell line from a Syrian hamster ductus deferens leiomyosarcoma) cells were obtained from the American Type Culture Collection, Rockville, Md., and grown at 37°C on 150-mm plastic culture dishes (Falcon) in Dulbecco's modified Eagle's medium supplemented with fetal bovine serum (5%), penicillin G (100 units/ml), streptomycin (0.1 mg/ml), and amphotericin B (2.5 ,g/ml) equilibrated with an atmosphere of 5% C02-95% air. Cells were seeded at 0.5x104 cells/cm2 and subcultured twice weekly after detachment by using 1 mM EDTA in phosphate-buffered saline. One-day preconfluent cultures were used for experiments.
Measurement of cAMP Content
Freshly isolated guinea pig ventricular myocytes were suspended in modified K-H solution containing adenosine deaminase (1 unit/ml) and 50 ,uM rolipram (to inhibit cAMP phosphodiesterase). Aliquots (400 ,ul) of the cell suspension, containing approximately 104 cells, were warmed to 34-35°C for 10 minutes. Drugs (or vehicle only) were added, and cells and drugs were incubated for 6 minutes. Hydrochloric acid (final concentration, 50 mM) was added to terminate the incubation. Samples were stored at 4°C until assay of cAMP content by the automated radioimmunoassay method of Brooker et al.31 DDT1MF-2 cells were rinsed twice with Hanks' balanced salt solution (HBSS), harvested with a cell lifter, pelleted by centrifugation at 1,000g for 5 minutes, and resuspended in HBSS. Aliquots of the cell suspension were warmed to 37°C for 10 minutes in HBSS containing 100 ,M rolipram. Drug incubation, termination, and assay of cAMP were carried out as stated for myocytes. Protein content of cell suspensions was determined using the Lowry method with bovine serum albumin as standard.
Pertussis Toxin Treatment
Adult guinea pigs were injected with pertussis toxin (150 ,g/kg) via the jugular vein. Seventy-two hours after the injection, the animals were killed, and cardiac myocytes were isolated (see "Preparation of Isolated Ventricular Myocytes"). To test the efficacy of pertussis toxin treatment, the effect of adenosine on APD50 of isolated myocytes was determined. The APD50 values of control myocytes were increased by isoproterenol (10 nM), and adenosine (100 ,M) abolished the prolongation of APD50 caused by isoproterenol. In contrast, adenosine (100 ,uM) failed to shorten the prolongation of the APD50 caused by isoproterenol in myocytes from pertussis-intoxicated animals.
In a separate series of experiments, isolated guinea pig ventricular myocytes rather than whole animals were pretreated for 3 hours with pertussis toxin (10 ,ug/ml), as stated in "Preparation of Isolated Ventricular Myocytes."
Cultures of DDT1MF-2 cells were pretreated by addition of pertussis toxin (25 ng/ml) to the culture media 18 hours before cells were to be used in experiments. Pretreatment with pertussis toxin abolished the inhibitory effect of 10 ,M N6-cyclopentyladenosine (an A1-adenosine receptor agonist) on isoproterenol-stimulated cAMP accumulation (not shown).
Isolated Perfused Hearts
Hearts of adult guinea pigs (n=5) were excised and perfused as described above ("Preparation of Isolated Ventricular Myocytes") with oxygenated warmed (35°C) K-H solution. Left ventricular pressure (LVP) was measured using a fluid-filled latex balloon placed in the left ventricle and connected to a pressure transducer (Gould P231D). Coronary perfusion pressure was measured using a pressure transducer connected to the perfusion line via a T connector. Pressures were recorded using an ink-chart recorder (Gould RS3400).
Each heart was paced at a rate 5-10% greater than its intrinsic rate by using a bipolar stimulating electrode placed on the base of the right ventricle. Electrical pacing was momentarily discontinued at appropriate times to allow measurement of spontaneous heart rate (HR). HR was determined from the recording of LVP.
The experimental protocol for determination of the effects of WRC-0090 on LVP and HR was as follows.
After an equilibration period of >30 minutes, control tially perfused for 4 minutes each with 1-, 10-, 100-, and 1,000-nM concentrations of WRC-0090 in K-H buffer. After a 10-minute washout period, hearts were exposed a second time 
Results
Effect ofA2-Adenosine Receptor Agonists on Ventricular Myocyte Action Potential Duration
APDs of ventricular myocytes were unaltered by exposure of myocytes to either the selective A2-adenosine receptor agonists WRC-0090 and WRC-0013 or by exposure to the unselective adenosine agonist NECA. Control values of APD50 for ventricular myocytes isolated from guinea pig (n=20), rabbit (n=3), and rat (n=3) hearts were 191±13 msec (mean±SEM, n=57), 162±12 msec (n=14), and 20±1 msec (n=12), respectively. Results of experiments using guinea pig isolated ventricular myocytes are shown in Figure 1 . Neither WRC-0090 (0.1 nM-10 ,uM) nor WRC-0013 (1-1,000 nM) caused a significant change in APD50 compared with control data ( Figure 1A) . Likewise, WRC-0090 or WRC-0013 did not alter either action potential amplitude or cellular resting membrane potential (data not shown). Because a possible A2-adenosine receptormediated increase in APD50 may have been "masked"
by an A1-adenosine receptor-mediated decrease in APD50, DPCPX (0.1 ,uM) or N-0861 (10 ,M) was used to inhibit a possible activation by WRC-0090 and WRC-0013 of the A1-adenosine receptor. However, there was no effect of either A2-agonist or of NECA on APD50 in the presence of DPCPX ( Figure 1B) or N-0861 (data not shown). Results similar to these with guinea pig myocytes were obtained with myocytes from rat (n=3) and rabbit (n=3) hearts (Figure 2 ). In contrast, isoproterenol (10 nM) caused increases of APD of 30-40% in guinea pig and 120% in rat ventricular myocytes compared with control data (data not shown). in either untreated or pertussis toxin-treated myocytes ( Figure 4 ). In contrast, isoproterenol (5 nM) increased APD50 in both untreated and treated myocytes ( Figure  4 ). As expected, pertussis toxin treatment nearly abolished the action of adenosine (100 ,uM) to attenuate an isoproterenol-mediated increase of APD50 ( Figure 4 ). The absence of an A2-adenosine receptor-mediated increase of APD50 could be the result of receptor desensitization by endogenous adenosine. To test this possibility, responses to adenosine and NECA were measured with cells that were isolated from two guinea pig hearts by using collagenase in the presence of theophylline (50 AM) and adenosine deaminase (1 unit/ml). Cells were pretreated with pertussis toxin (10 ,gg/ml), also in the presence of theophylline and adenosine deaminase, for 3 hours at 37°C and then washed three times to remove theophylline. The response of these cells to adenosine (10 and 
Effects of WRC-0090 on Shortening of Isolated Ventricular Myocytes
The selective A2-adenosine receptor agonist WRC-0090 (0.1-1,000 nM) did not increase the amplitude of shortening of guinea pig (Figures 7 and 8 ) or rat ( Figure  8 ) isolated ventricular myocytes. In contrast, isoproterenol (10 nM) elicited an increase in the amplitude of shortening (Figures 7-9) . A high concentration of WRC-0090 (10 ,uM) attenuated the action of isoproterenol ( Figure 9 ). Attenuation by WRC-0090 of the isoproterenol-induced increase in shortening was antagonized by 0.1 ,uM DPCPX ( Figure 9 ). NECA (10 ,uM) in the presence of 0.1 juM DPCPX did not increase shortening of guinea pig isolated ventricular myocytes (data not shown). Similar results were obtained using ventricular myocytes from rabbits and rats (n= 11 and 19 myocytes from two and four hearts, respectively; data not shown). Twitch amplitude of guinea pig isolated myocytes pretreated for 3 hours with pertussis toxin (10 ng/ml) and adenosine deaminase (1 unit/ml) was unaltered either by WRC-0090 (1 ,uM) (Figure 10 ) or by NECA (10 ,uM, not shown), whereas isoproterenol (10 nM) increased the twitch amplitude of the same cells by more than fourfold ( Figure 10) pertussis toxin and adenosine deaminase did not "uncover" a stimulatory A2-adenosine receptor-mediated response. Although both WRC-0090 (1 jiM) and NECA (10 ,uM) slightly increased cAMP accumulation in pertussis toxin-treated myocyte preparations in the presence of rolipram and N-0861, these increases did not reach statistical significance (Figure 12 ). In contrast, isoproterenol (0.1 ,uM) caused a threefold increase of cAMP content in pertussis toxin-treated myocytes that was not antagonized by 5 ,iM N6-cyclopentyladenosine, a selective A1-adenosine agonist (Figure 12 ). Adenosine increased cAMP content of myocytes slightly but not significantly. In two experiments, guinea pig ventricular myocytes were isolated in the presence of adenosine deaminase (1 unit/ml) and theophylline (50 ,uM) (see 'Preparation of Isolated Ventricular Myocytes') and studied after incubation with pertussis toxin (10 jig/ml). cAMP contents of aliquots of cells incubated with 5 ,uM erythro-9-(2-hydroxy-3-nonyl)adenine (an inhibitor of adenosine deaminase), 0.1 ,uM DPCPX, and 50 ,LM rolipram in the absence or pres-WRC-0090 concentration (-log M) FIGURE 11. Graph showing the absence of effect of 2-[2-(4-methylphenyl)ethoxy]adenosine (WRC-0090) on cAMP content ofisolated guinea pig ventricular myocytes in the presence and absence of the selective A1-adenosine receptor antagonist (4-)N6-endonorbornan-2-yl-9-methyladenine (N-0861, 10 ,uM). Each ,uM), and N6-cyclopentyladenosine (CPA, 5 ,uM) on cAMP accumulation in guinea pigpertussis toxin-treated ventricular myocytes. C, control (no drug); NS, not significantly different from control. Isolated myocytes were pretreated at 37°Cfor 3 hours with pertussis toxin (10 ig/ml) and adenosine deaminase (1 unit/ml). Aliquots ofpertussis toxin-treated myocytes were incubated for 6 minutes at 34°C in modified KrebsHenseleit buffer containing adenosine deaminase (1 unit/ml), (±)N6-endonorbornan-2-yl-9-methyladenine (10 JIM), the phosphodiesterase inhibitor rolipram (50 jiM), and indicated drugs. Bars indicate mean and SEM of six or seven total determinations in three independent experiments. *p <0. 01 vs. control by Newman-Keuls test.
ence of 10 ,uM or 100 ,uM adenosine were 7.89±0.25
pmol (mean+±SEM, n=6), 9 .05±0.38 pmol (n=5), and 9.79±0.15 pmol (n=6), respectively (p>0.05 versus control by ANOVA). In contrast, cAMP content of cells incubated with 0.1 ,uM isoproterenol was increased significantly to 27.9±1.5 pmol (n=5). The A1-adenosine receptor agonist N-cyclopentyladenosine did not attenuate the isoproterenol-induced increase of cAMP accumulation in these pertussis toxin-treated cells. cAMP content of cells incubated with N6-cyclopentyladenosine (5 ,uM) and isoproterenol (0.1 ,uM) was 28.1±2.7 pmol (n=5). This result suggests that A1-adenosine receptormediated responses were absent. In summary, although adenosine, NECA, and WRC-0090 (above) increased cAMP accumulation by a small amount, because the increase was not statistically significant, its relevance is questionable.
The effects of WRC-0090 and of WRC-0013 on cAMP accumulation in DDT1MF-2 cells were biphasic. cAMP accumulation increased as WRC-0090 concentration was raised from 1 to 300 nM and then fell when WRC-0090 concentration was increased further ( Figure  13 ). When DPCPX (0.1 ,uM) was present to antagonize the action of WRC-0090 at A,-adenosine receptors or when cells were pretreated with pertussis toxin to uncouple A1-adenosine receptors from inhibitory G proteins, WRC-0090 concentrations from 1 nM to 100 ,uM caused cAMP content to increase, with a maximum response at .0.3 ,uM WRC-0090 ( Figure 13 ). The action of WRC-0090 to increase cAMP accumulation in DDT1MF-2 cells was not antagonized to a significant extent by either 10 ,uM N-0861 or 0.1 ,uM DPCPX (Figure 14) . On the other hand, 5 ,uM xanthine amine congener and 0.2 ,uM DPCPX significantly reduced the cAMP response to 0.1 juM WRC-0090 by 75% and 12%, respectively (Figure 14) . The anticipated responses to activation of putative A2-adenosine receptors were not revealed in mammalian ventricular myocytes by attenuating the opposing responses mediated by A1-adenosine receptors. Pertussis toxin treatments of either whole animals or isolated myocytes attenuated the actions of A1-adenosine receptor agonists to reduce isoproterenol-mediated increases of either APD50 or cAMP accumulation. However, after myocytes were pretreated with pertussis toxin, neither APD50 ( Figures 3 and 4) nor contractile amplitude ( Figure 10 ) nor cAMP content ( Figure 12 ) was significantly elevated by the A2-adenosine receptor agonists tested (WRC-0090, WRC-0013, NECA, and adenosine). Similarly, A2-adenosine receptor agonists did not alter APD50 (Figures 1-4) , contractile amplitude (Figures 8 and 10 ), or cAMP content (Figures 11 and 12 ) in the presence of the A1-adenosine receptor antagonists a1t141 N-0861 (10 gM) or DPCPX (0.1 gM), both of which have been shown to antagonize the actions of Alagonists in the heart.l925 Although the A1/A2 selectiveness of 0.1 gM DPCPX and 10 ,uM N-0861 could not be assessed with cardiac myocytes, results of experiments using DDT1MF-2 cells (Figures 13 and 14) indicated that these adenosine receptor antagonists did not significantly reduce a WRC-0090-mediated elevation of cAMP content (an A2-adenosine receptor-mediated response). Thus, our inability to demonstrate functional responses to A2-adenosine receptor agonists using either pertussis toxin pretreatment of myocytes, selective A,-antagonists, or both does not appear to be the result of either an incomplete attenuation of A,-adenosine receptor-mediated responses or an inadvertent antagonism of the putative A2-adenosine receptor.
Because proteolytic digestion of the heart to isolate myocytes may have caused damage to adenosine receptors, we tested the effect of the selective A2-adenosine receptor agonist WRC-0090 on the guinea pig isolated perfused heart. WRC-0090 (1-1,000 nM) had no significant effects on HR or LVP in either the presence or absence of 0.1 gM DPCPX. This result suggests that guinea pig cardiac myocytes in situ do not possess functional A2-adenosine receptors. Also, the lack of A2-adenosine receptor-mediated responses in isolated myocytes did not appear to be an artifact of trypsin or dispase digestion of the heart. When hearts were digested with collagenase alone and myocytes were allowed to recover in medium 199 at 37°C for 3 hours, A2-adenosine receptor-mediated responses were absent (Figures 4, 10, and 12) , whereas responses to isoproterenol and adenosine (A1) were present. Furthermore, desensitization of A2-adenosine receptors by endogenous adenosine during isolation of myocytes did not appear to explain our negative findings. We were unable to demonstrate electrophysiological responses to adenosine (10 and 100 gM) or to NECA (10 and 100 gM) with guinea pig myocytes that had been isolated in the presence of theophylline (50 gM) and adenosine deaminase (1 unit/ml) (to prevent desensitization of adenosine receptors and accumulation of adenosine, respectively) and pretreated with pertussis toxin to uncouple activation of A1-adenosine receptors from functional responses. However, despite precautions to prevent loss of putative A2-adenosine receptors and measures to reduce A,-adenosine receptor-mediated inhibitory responses, the possibility still exists that the experimental conditions and/or drugs chosen for this study were not ideal for demonstration of A2-adenosine receptors on ventricular cardiomyocytes.
The A2-adenosine receptor agonists used in this study were determined to be highly selective in the guinea pig isolated perfused heart.23 '24 We have confirmed this selectivity using the DDT1MF-2 cell line. Both WRC-0090 and WRC-0013 potently increased cAMP content of DDTIMF-2 cells (Figure 13 and text) . However Adenosine at high concentrations (0.1 and 1 mM) has been reported to exert a small (6-20%) positive inotropic effect on papillary muscles isolated from rat,34 guinea pig,35 and human36 ventricles. The adenosine analogues NECA and R-PIA do not appear to elicit this effect.35-37 To our knowledge, the positive inotropic effect of adenosine in mammalian ventricles has not been demonstrated to be receptor mediated, and its mechanism is unknown, although a stimulation of inositol phosphate formation may be involved. 34 The fact that a significant adenosine receptor-mediated positive inotropic effect in ventricular myocardium has not been consistently demonstrated suggests that the physiological importance of this effect is minor.
The presence of adenosine receptors stimulating adenylyl cyclase activity in myocytes was suggested by investigators studying responses of guinea pig myocardial slices,15 crude homogenates of cultured myocytes,17 sarcolemmal membrane preparations,1819 and isolated intact myocytes20 to unselective adenosine receptor agonists. Using membranes prepared from adult rat ventricular myocytes, Romano et al19 found that adenylyl cyclase activity was increased by NECA (1-100 ,M) in the presence but not the absence of DPCPX. Behnke et a120 measured both the contractile response and the cAMP content of guinea pig isolated ventricular myocytes after exposure of cells to adenosine analogues in the presence of isoproterenol (0.1 ,uM). R-PIA decreased both the contractile response and the cAMP content of myocytes. In contrast, NECA decreased the contractile response to isoproterenol, but cAMP content of cells either was not changed (in the presence of NECA alone), increased (NECA with 0.3 ,M DPCPX), or decreased (NECA with the A2-adenosine receptor antagonist CGS 15943A). The authors concluded that guinea pig ventricular myocytes possessed both A,-adenosine receptors that inhibited the contractile and cAMP responses to isoproterenol and A2-adenosine receptors that increased cAMP content but did not alter contractility.20 However, some investigators using mammalian isolated ventricular myocyte preparations exposed to adenosine analogues have observed only A1-adenosine 
